compatible smartphone with the Dexcom Stelo sensor system
have not have worn a CGM in the last 6 months prior to enrollment
You may not be if
any of the following forms of diabetes: type 1 diabetes, type 2 diabetes, monogenic diabetes, cystic fibrosis-related diabetes, post- transplant diabetes, latent autoimmune diabetes
problematic hypoglycemia in the prior 6 months \[defined as recurrent (more than one) level 2 hypoglycemic events (glucose \<54mg/dL ) that persist despite multiple attempts to adjust medication(s) and/or modify the diabetes/treatment plan or a history of one level 3 hypoglycemic event (glucose \<54mg/dL) characterized by altered mental and/or physical state requiring third-party assistance for treatment of hypoglycemia\]
pregnant, or planning to become pregnant during the study time frame
currently receiving or planned to receive dialysis during the study time frame - current use of systemic steroids for any condition
a known allergy to medical grade adhesives,
use of any CGM device in the past 6 months
history of a diagnosed eating disorder
current use of a second-generation antipsychotic at the time of consent (aripiprazole, asenapine, brexpiprazole, cariprazine, clozapine, iloperidone, lurasidone, olanzapine, paliperidone, quetiapine, risperidone, ziprasidone)
subjects lacking capacity to provide informed consent
Clareo Health | Pharmacist-Led Continuous Glucose Monitoring for Prediabetes
